Literature DB >> 33485048

Microwave ablation for the removal of pharyngeal benign lesions: A prospective pilot case series.

ZhiGuo OuYang1, Zihan Lou2, Zhengcai Lou3, Kangfen Jin1, Junzhi Sun1, Zhengnong Chen4.   

Abstract

OBJECTIVE: We evaluated microwave ablation (MWA) for treatment of isolated pharyngeal benign lesions, in terms of technical feasibility, efficacy, and safety.
METHODS: The patients with pharyngeal benign lesions were treated with endoscopic MWA with a 2450-MHz single cooled-shaft microwave antenna and sent for histological examination. Postoperative pain intensity was measured via visual analogue scale (VAS) on the 12th hour and the third postoperative days.
RESULTS: Of the 137 patients with pharyngeal benign lesions who met the inclusion criteria. The most commonly involved site was the uvula (n = 66, 48.2%), followed by the lateral pharyngeal wall (n = 37, 27.0%), the nasopharyngeal posterior wall (n = 23, 16.8%) and the soft palate (n = 11, 8.0%). All of the procedures were completed using local anesthesia and were well-tolerated by the patients. The ablation time was 5-10 min, with an average duration of 6.3 ± 1.8 min. The most common pathology was papilloma (n = 96, 70.1%), followed by nasopharyngeal cysts (n = 21, 15.3%), polyp (n = 10, 7.3%), epidermoid cysts (n = 8, 5.8%) and Thornwaldt cysts (n = 2, 1.5%). The mean VAS pain score was 2.36 ± 1.08 on postoperative 12th hour and 1.21 ± 0.54 on postoperative third day. At the 6-month follow-up examination, there were no severe complications, such as recurrence, bleeding, or synechiae of the nasal cavity, eustachian tube injury, in any of the patients.
CONCLUSIONS: The MWA for the treatment of isolated pharyngeal benign lesion is feasible and alternative to conventional surgical methods, it allows excision of the lesion while providing hemostasis, involves only a short ablation time and has a very low risk of complications. Most of our patients well-tolerate the procedure, which may be performed under local anesthesia in the outpatient setting.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Benign lesion; Microwave ablation; Pharynx; VAS pain score

Year:  2021        PMID: 33485048     DOI: 10.1016/j.amjoto.2021.102916

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  1 in total

1.  Microwave ablation eustachian tuboplasty: a preliminary investigation with long-term follow-up.

Authors:  Zhengcai Lou; Zihan Lou; Junzhi Sun; Zhengnong Chen; Shankai Yin
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.